Giampaolo Trivellin Selected Research

aryl hydrocarbon receptor-interacting protein

10/2020	Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
1/2020	Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway.
1/2020	HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
1/2018	Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).
1/2017	Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.
2/2016	Pituitary gigantism: update on molecular biology and management.
1/2016	Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations.
9/2015	Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
1/2013	Genetics of pituitary adenomas.
9/2012	MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giampaolo Trivellin Research Topics

Disease

18	Pituitary Neoplasms (Pituitary Adenoma) 04/2022 - 01/2012
14	Neoplasms (Cancer) 10/2020 - 08/2012
9	Gigantism 01/2022 - 01/2012
8	Acromegaly 01/2018 - 01/2012
6	Adenoma (Adenomas) 01/2016 - 08/2011
4	Familial Isolated Pituitary Adenoma 10/2016 - 08/2010
3	Carney Complex 10/2020 - 02/2016
3	Hyperplasia 03/2016 - 06/2015
3	Growth Hormone-Secreting Pituitary Adenoma 01/2015 - 08/2012
2	Carcinogenesis 10/2020 - 01/2016
2	Pituitary ACTH Hypersecretion 01/2019 - 01/2016
2	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2016 - 02/2016
1	Glioma (Gliomas) 04/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 04/2022
1	Meningioma (Meningiomas) 01/2020
1	Hypopituitarism (Sheehan's Syndrome) 01/2020
1	Craniopharyngioma (Craniopharyngiomas) 01/2020
1	Diabetes Insipidus 01/2020
1	Headache (Headaches) 01/2020
1	Prolactinoma (Prolactinomas) 01/2018
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2018
1	Multiple Endocrine Neoplasia Type 1 10/2016
1	Nephrogenic Diabetes Insipidus 05/2016
1	Polyuria 05/2016
1	Polydipsia 05/2016
1	Weight Gain 05/2016
1	Paraganglioma (Paragangliomas) 02/2016
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 02/2016
1	Pheochromocytoma 02/2016
1	Growth hormone excess 02/2016
1	Myxoma (Myxomas) 01/2016
1	Lentigo (Lentiginosis) 01/2016
1	ACTH-Secreting Pituitary Adenoma 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013
1	Carcinoma (Carcinomatosis) 07/2012

Drug/Important Bio-Agent (IBA)

14	aryl hydrocarbon receptor-interacting proteinIBA 10/2020 - 08/2010
7	Growth Hormone (Somatotropin)IBA 04/2022 - 01/2013
6	ProlactinIBA 04/2022 - 08/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2016
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 08/2012
4	Proteins (Proteins, Gene)FDA Link 04/2017 - 01/2012
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2020 - 01/2016
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 08/2012
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2016
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2016 - 02/2016
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2016 - 07/2012
2	Messenger RNA (mRNA)IBA 01/2015 - 07/2012
1	Adenosine Monophosphate (AMP)IBA 10/2020
1	Hormones (Hormone)IBA 01/2020
1	Cyclic AMP (AMP, Cyclic)IBA 01/2020
1	pegvisomant FDA LinkGeneric 01/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2018
1	Arginine Vasopressin (Argipressin)IBA 05/2016
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 05/2016
1	Pituitary HormonesIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Mutant Proteins (Protein, Mutant)IBA 01/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2015
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 12/2013
1	SNARE Proteins (SNAREs)IBA 12/2013
1	5' Untranslated Regions (5' UTR)IBA 03/2013
1	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2013
1	MicroRNAs (MicroRNA)IBA 09/2012
1	lanreotide (Somatuline)FDA Link 08/2012
1	GalactosidasesIBA 07/2012
1	Biological ProductsIBA 07/2012

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2015
1	Hypophysectomy 01/2018